ASTELLAS PHARMA EUROPE B.V.

Company Introduction:

Astellas Pharma Europe B.V. is the European regional headquarters and commercial arm of Astellas Pharma Inc., a global pharmaceutical company based in Japan. Its primary role is to manage the sales, marketing, and distribution of Astellas' pharmaceutical products across Europe, focusing on delivering innovative medicines to patients in the region.

Classification:

Astellas Pharma Europe B.V. functions as a trader and distributor of pharmaceutical products. It is not a factory or a manufacturing facility. While its parent company, Astellas Pharma Inc., operates manufacturing sites worldwide, Astellas Pharma Europe B.V. primarily handles the commercial and supply chain operations for the European market. Any operations of Astellas in India are managed by other dedicated Astellas entities specific to the Indian market, not by Astellas Pharma Europe B.V. itself.

Astellas Pharma Europe B.V. is the European regional headquarters for Astellas Pharma Inc., a Japanese multinational pharmaceutical company. While Astellas Pharma Europe B.V. itself does not directly manufacture products in India, Astellas Pharma products are sold and distributed in India through its local operations or partners.

The following are some of the key products from Astellas Pharma that are generally available or have been available in the Indian market:

Xtandi (enzalutamide) - Used for the treatment of prostate cancer.

Vesicare (solifenacin succinate) - Used for the treatment of overactive bladder.

Betmiga (mirabegron) - Used for the treatment of overactive bladder.

Prograf (tacrolimus) - An immunosuppressant used in organ transplant recipients.

Xospata (gilteritinib) - Used for the treatment of acute myeloid leukemia.